900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Thiothixene hydrochloride 5mg powder for injection solution vial	Product containing only tiotixene in parenteral dose form (medicinal product form)
Thiothixene hydrochloride 5mg/mL oral solution	Tiotixene 5 mg/mL oral solution
Third degree atrioventricular block	Complete atrioventricular block
Third diphtheria and tetanus double vaccination	Administration of third dose of diphtheria and tetanus vaccine
Third diphtheria and tetanus double vaccination	Administration of third dose of diphtheria and tetanus vaccine
Third diphtheria, pertussis and tetanus triple vaccination	Administration of third dose of diphtheria, pertussis, and tetanus vaccine
Third diphtheria, pertussis and tetanus triple vaccination	Administration of third dose of diphtheria, pertussis, and tetanus vaccine
discographie thoracique	Discography with injection of contrast into intervertebral disc of thoracic spine (procedure)
Thoracic mesothelioma TNM finding	American Joint Committee on Cancer allowable value
Thoracic somatic dysfunction	Somatic dysfunction of thoracic region (finding)
Thoracoabdominal aortic aneurysm, without mention of rupture	Thoracoabdominal aortic aneurysm
Thorny headed worm	Phylum Acanthocephala (organism)
Thousands/microliter	x10^3/microliter
Threatened abortion (antepartum)	Threatened miscarriage
Threatened abortion - delivered	Threatened miscarriage
Threatened abortion, unspecified as to episode of care	Threatened miscarriage
Three hundred and sixty degree translocation of macula	Translocation of retina (procedure)
Throat anti-infective preparation	Product manufactured as oromucosal dose form (product)
Throat preparation	Product manufactured as oromucosal dose form (product)
Thrombocytopenia: [congenital purpura] or [hereditary NEC]	Hereditary thrombocytopenic disorder (disorder)
trombofilie door verworven proteïne C-deficiëntie	Acquired protein C deficiency (disorder)
trombofilie door verworven proteïne S-deficiëntie	Acquired protein S deficiency
Thrombosis of renal vein	Thrombosis of renal vein
Thrombotic microangiopathy NOS	Thrombotic microangiopathy (disorder)
thrombus door hulpmiddel, implantaat en/of transplantaat	Thrombosis (disorder)
Thumb pulp flap	Flap (substance)
Thymoma - category	Thymoma
Thymoma, no International Classification of Diseases for Oncology subtype	Thymoma of uncertain behaviour
Thymoma, type A	Thymoma, type A, malignant
Thymoma, type AB	Thymoma, type AB, malignant
Thymoma, type B1	Thymoma, type B1, malignant
Thymoma, type B2	Thymoma, type B2, malignant
Thymoma, type B3	Thymoma, type B3, malignant
Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial	Product containing only thymalfasin (medicinal product)
Thymosin alpha 1 1.6mg powder for injection solution vial + diluent	Product containing only thymalfasin (medicinal product)
Thymoxamine 0.5% conventional release eye drops	Product containing only moxisylyte in ocular dose form (medicinal product form)
Thymoxamine 0.5% preservative-free eye drops	Product containing only moxisylyte in ocular dose form (medicinal product form)
Thyroid TNM finding	American Joint Committee on Cancer allowable value
Thyroid eye disease with exophthalmos	Exophthalmos due to thyroid eye disease (disorder)
Thyroid eye disease with strabismus	Exophthalmos due to thyroid eye disease (disorder)
Thyroid gland excision	Thyroidectomy
Thyroid related antibody	Thyroid antibody
Thyrotropin alfa 0.9mg/mL powder for injection solution vial	Thyrotrophin only product
Thyrotropin alfa 1.1mg/vial powder	Thyrotrophin only product
Thyroxine sodium 100micrograms tablet	Levothyroxine sodium anhydrous 100 microgram oral tablet
Thyroxine sodium 25micrograms tablet	Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug)
Thyroxine sodium 50micrograms tablet	Levothyroxine sodium anhydrous 50 microgram oral tablet
Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial	Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 1g powder for injection solution vial	Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 20g powder for injection solution vial	Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 3g powder for injection solution vial	Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
Tiludronate disodium	Product containing tiludronic acid (medicinal product)
Time since symptom started NOS	Symptom findings in relation to start time
Time since symptom started NOS	Symptom findings in relation to start time
Time symptom lasts NOS	Symptom findings in relation to time lasts (finding)
Time symptom lasts NOS	Time symptom lasts
Time zone syndrome	Jet lag (finding)
Timed unsupported steady stand test	Timed unsupported steady stand time
Timolol maleate 0.25% ophthalmic solution	Timolol (as timolol maleate) 2.5 mg/mL eye drops
Timolol maleate 0.5%	Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Timolol maleate 0.5% ophthalmic solution	Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Timolol maleate+bendroflumethiazide	Product containing bendroflumethiazide and timolol (medicinal product)
Tiotropium 18microgram inhalation powder capsule	Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation
Tiotropium 18microgram inhalation powder capsule with device	Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation
Tis (0): Carcinoma in situ (limited to fallopian tube mucosa)	cTis
Tis (0): Carcinoma in situ (vagina)	cTis
stade Tis	cTis
Tis: Carcinoma in situ ("flat tumor" of urinary bladder)	cTis
Tis: Carcinoma in situ (endometrium/uterine cervix)	cTis
Tis: Carcinoma in situ	cTis
Tis: Epithelium only (carcinoma in situ, no invasion)	cTis
Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis)	cTis
Tis: Tumor invades lamina propria (gastrointestinal tumor)	American Joint Committee on Cancer cTis(LAMN) (qualifier value)
Tis: Tumor invades muscularis mucosae (colon/rectum)	cTis
Tissue culture for chromosome analysis, more complex procedure with special extra counts	Chromosome analysis
Tissue injection for local action	Injection into body tissue for local action
Tissue injection for local action NOS	Injection into body tissue for local action
Tissue injection for local action NOS	Injection into body tissue for local action
Tissue kallikrein	Kininogen
Tissue processing technique, complex, embed, cut and stain, per autopsy	Tissue processing technique
Tissue processing technique, complex, embed, cut and stain, per surgical specimen	Tissue processing technique
Titanium dioxide 20% paste	Product containing only titanium dioxide (medicinal product)
afhankelijkheid van tabak met huidig gebruik	Tobacco dependence syndrome
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension	Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)
Tobramycin 1.2g powder for injection solution vial	Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial
Tobramycin 1.2mg/mL injection	Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial
Tobramycin 300mg/5mL nebulizer solution	Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug)
Tobramycin 60mg/mL solution	Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug)
Tocilizumab 20mg/mL conventional release solution for injection	Tocilizumab only product in parenteral dose form
Tocilizumab 20mg/mL solution for intravenous infusion	Tocilizumab only product in parenteral dose form
Tocopherol	Vitamin E and/or vitamin E derivative (substance)
Toe flap	Flap (substance)
Tolnaftate+chlorhexidine hydrochloride	Product containing chlorhexidine and tolnaftate (medicinal product)
Tolterodine 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine L-tartrate 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine L-tartrate 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine L-tartrate 4mg prolonged-release oral capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine tartrate 2mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine tartrate 2mg prolonged-release oral capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine tartrate 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Toluene diisocyanate specific extract	Toluene-2-4-diisocyanate

Start Previous Page 136 of 155 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
7237811000172118	referentieset voor associaties betreffende vervangende concepten	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)